Skip to main content

Column Group II, LP's Form 4 filing

RAPT Therapeutics, Inc.RAPT · filed May 27, 2022

Accession no.
0000899243-22-019940
Filed
May 27, 2022, 4:29 PM ET
Trade date
May 25, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market purchases total $23.7K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Column Group II, LPCIK 000160042010% Owner
Column Group IV-A, LPCIK 000179635310% Owner
Column Group IV, LPCIK 000179635410% Owner
Column Group IV GP, LPCIK 000179635610% Owner
TCG IV GP, LLCCIK 000179635910% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 25, 2022Common StockPPurchaseAcquired+1,837$12.45F1+$22,879.651,236,261IndirectDuplicate filing
May 25, 2022Common StockPPurchaseAcquired+63$12.45F1+$784.6642,189IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.44 to $12.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of securities purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Referenced by the price of 2 transactions in Table I.

Remarks

Due to SEC restrictions on the number of reporting owners, this is Form 2 of 2.

Read the full filing on SEC EDGAR (opens in a new tab)